Aegon Ltd. - New York Shares posts a EBIT of $-4.2B as of June 2026. That compares with $9.4B in the prior-year period — down 145.1% year over year. That is below the Finance sector average of $350B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Aegon Ltd. - New York Shares's EBIT was $9.4B. The latest reading is $-4.2B — a 145.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Finance stocks, a EBIT near $350B is typical. Aegon Ltd. - New York Shares's $-4.2B is lower that level. That is roughly 101.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Aegon Ltd. - New York Shares's financial statement story. At $-4.2B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AEG's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $350B), and (3) consistency with growth and profitability. This page covers the first two; Aegon Ltd. - New York Shares's other metric pages and overview cover the third.